Serious liver side effects detour Amgen's effort to expand use of its KRAS-blocking lung cancer drug

Retrieved on: 2022-08-07 11:03:44

Tags for this article:

Click the tags to see associated articles and topics

Serious liver side effects detour Amgen's effort to expand use of its KRAS-blocking lung cancer drug. View article details on hiswai:

Excerpt

Health Tech Mario Aguilar · How much are patients actually using mental health apps? ... Reporting from the frontiers of health and medicine.

Article found on: www.statnews.com